Kenan Thompson flashed a “Mighty Ducks 4” script — after Disney rejected his co-star Emilio Estevez’s pitch for a fourth installment of the franchise — at the Anaheim Ducks game on Sunday. In a clip ...

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson The reporters have ...

Landing a white-collar job is getting so tough that candidates—not companies—are paying recruiters to match them with positions. Through good economic times and bad, recruiters have usually operated ...

From first-quarter lulls to impossible catches, here’s why every Super Bowl feels like it was written in advance – even when it isn’t. Let's clear the air before you read another word: I do not ...

Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at ...

I love Express Script, they are great! I get my meds cheap and the pharmacist are all helpful. I cannot say that for all customer service people but they do a great job as well. Just like every ...

The Federal Trade Commission has agreed to what it called a “landmark” settlement with Express Scripts, allowing the company to bow out of the agency’s lawsuit against major pharmacy benefit managers ...

Evernorth Health, Inc. operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company’s PBM segment offers medicine purchase and tracking through a mobile ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

President Donald Trump’s sudden shift toward restraint wasn’t taken as goodwill — it was taken as weakness. Within hours, the Clintons responded with a coordinated counterstrike that left no doubt ...

FTC allegations centered on “Big 3” PBMs using anticompetitive rebating and affiliated-pharmacy channel dynamics to inflate insulin list prices and capture rebate and margin-driven revenues.